TURKISH JOURNAL OF HEMATOLOGY, vol.28, no.3, pp.176-185, 2011 (SCI-Expanded)
Objective: Treatment of acute lymphoblastic leukemia (ALL) in adults focuses on the initial assessment of the prognostic relevant cytogenetic features as well as a response-guided therapy based on molecular data. We examined the importance of molecular-cytogenetic abnormalities for complete remission (CR) rates and the overall survival (OS) in adult ALLs.